Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Edmund Grzeskowiak"'
Publikováno v:
Anaesthesiology Intensive Therapy, Vol 56, Iss 2, Pp 129-140 (2024)
Externí odkaz:
https://doaj.org/article/8bbb1ddd7429467a924cd4af42b63bfd
Autor:
Konrad Lewandowski, Agnieszka Karbownik, Andrzej Czyrski, Hanna Urjasz, Joanna Stanisławiak-Rudowicz, Edmund Grześkowiak, Edyta Szałek
Publikováno v:
Acta Poloniae Pharmaceutica, Vol 81, Iss 2, Pp 263-278 (2024)
Olaparib, an oral poly-ADP ribose polymerase (PARP) inhibitor, is a relatively new anticancer drug. It is essential to find TDM-guided dosage for better safety and tolerability of patients. However, first, it is important to develop a suitable analyt
Externí odkaz:
https://doaj.org/article/d88f74306b6e406baae09e6342e10085
Autor:
Anna Wolc, Agnieszka Karbownik, Edmund Grzeskowiak, Joanna Porażka, Edyta Szałek, Anna Luczak, Artur Teżyk, Tomasz Grabowski
Publikováno v:
Acta Poloniae Pharmaceutica - Drug Research. 76:645-651
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c642b1310873dcf115abbbad4edc3746
https://doi.org/10.32383/appdr/104370
https://doi.org/10.32383/appdr/104370
Publikováno v:
FARMACIA. 66:791-797
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7121acf212ad62bf66df311092af5831
https://doi.org/10.31925/farmacia.2018.5.8
https://doi.org/10.31925/farmacia.2018.5.8
Publikováno v:
Acta Poloniae Pharmaceutica, Vol 80, Iss 4, Pp 521-530 (2023)
Sore throat is a common symptom that accompanies infectious and non-infectious diseases. World standards of sore throat treatment mainly regulate approaches to the diagnosis of the streptococcal nature of sore throat and the use of antibacterial ther
Externí odkaz:
https://doaj.org/article/63c7a13cc4314e28bd84da4f192b87ae
Autor:
Danuta Szkutnik-Fiedler, Filip Kwiatkowski, Monika Chomej, Dorota Kołodziej, Michał Michalak, Edmund Grześkowiak, Edyta Szałek
Publikováno v:
Acta Poloniae Pharmaceutica, Vol 80, Iss 2, Pp 277-287 (2023)
Most hospitalized patients with COVID-19 require complex pharmacotherapy due to underlying diseases, and polypharmacy may significantly increase the risk of drug-drug interactions (DDIs) and, in consequence, trigger adverse effects. The aim of this s
Externí odkaz:
https://doaj.org/article/2824e5cbbb024d909c0d9315f543c220
Publikováno v:
Neuropsychiatry.
It is known that there is a strong relationship between chronic pain and depression, and both of these diseases can intensify each other. In addition to mental illnesses, there are also a number of somatic symptoms, including pain. While pain, especi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::533e7d7c51f72f83320dc53a797fba11
https://doi.org/10.4172/neuropsychiatry.1000327
https://doi.org/10.4172/neuropsychiatry.1000327
Autor:
Marcin Ożarowski, Radosław Kujawski, Przemysław Mikołajczak, Edmund Grzeskowiak, Bogusław Czerny, Beata Mrozikiewicz-Rakowska, Przemyslaw M. Mrozikiewicz, Joanna Bartkowiak-Wieczorek, Anna Bogacz
Publikováno v:
Acta Pharmaceutica, Vol 64, Iss 2, Pp 223-232 (2014)
Acta Pharmaceutica
Volume 64
Issue 2
Acta Pharmaceutica
Volume 64
Issue 2
There are a number of compounds that can modify the activity of ABC (ATP-binding cassette) and SLC (solute carrier) transporters in the blood-brain barrier (BBB). The aim of this study was to investigate the effect of natural and synthetic substances
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42920b20a5b8b1a27c57b98c9677380e
http://www.degruyter.com/view/j/acph.2014.64.issue-2/acph-2014-0020/acph-2014-0020.xml?format=INT
http://www.degruyter.com/view/j/acph.2014.64.issue-2/acph-2014-0020/acph-2014-0020.xml?format=INT
Autor:
Arkadiusz Adamiszak, Tomasz Torliński, Edmund Grześkowiak, Alicja Bartkowska-Śniatkowska, Agnieszka Bienert
Publikováno v:
Farmacja Polska, Vol 78, Iss 7, Pp 390-402 (2022)
The COVID-19 pandemic has driven the experimental, off-label treatments with co-administration of supportive therapies for many patients with severe infections and coexisting chronic conditions. This situation has inevitably led to polypharmacy, whic
Externí odkaz:
https://doaj.org/article/5a2fa7f05f214e979488b8f05be44f07
Publikováno v:
Scopus-Elsevier
Antibiotics are the most commonly used drugs in intensive care unit patients and their supply should be based on pharmacokinetic/pharmacodynamic rules. The changes that occur in septic patients who are critically ill may be responsible for subtherape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194c9e70e85cfc44f4a48904cc97cb24
https://doi.org/10.2174/1574884711308010004
https://doi.org/10.2174/1574884711308010004